Site na ihe na-enyere aka, "famotidine"? Ntuziaka maka ojiji, n'ezie

Ị maara na site na ihe na-enyere "famotidine"? Zaa ajụjụ a nwere ike na dọkịta. Ọ bụrụ na oge a oge na a dọkịta ị na-adịghị, mgbe ahụ, anyị ga-ekwu okwu banyere nke a ọgwụ a n'isiokwu a.

Ị ga-amụta ihe Njirimara kwuru agwọ ọrịa, dị ka ọ na-anọchi, na ihe ọrịa na-eji, ihe ndị so na ya na mejupụtara, na na.

Mejupụtara nke ọgwụ nkwakọ, na ụdị nkọwa

Na ihe ụdị ntọhapụ agwọ ọrịa "famotidine"? Manual na-ekwu na ngwá ọrụ a nwere ike dị na ụdị mbadamba. Ha nwere a lenticular okirikiri udi, nakwa dị ka film ntekwasa acha aja aja ma ọ bụ acha odo odo.

Gịnị bụ ndị Efrata na-agụnye ọgwụ "famotidine"? The mejupụtara nke ọgwụ dị mfe: isi mgwa - famotidine. E wezụga isi ihe onwunwe, na ngwá ọrụ gụnyere a nkwado, dị ka microcrystalline cellulose, ọka starch, magnesium stearate, talc, sịlịkọn dioxide na croscarmellose sodium.

Banyere mbadamba, ọ na-agụnye macrogol 6000, hypromellose, talc, titanium dioxide na ígwè oxide aja aja e ji esiji ákwà.

The ire echiche na nkà mmụta ọgwụ na-abịa na ọnya Ukwu, nke na-packaged ke akwụkwọ nkwakọ.

Ọ ga-ọ pụta ìhè na nkwadebe "nke famotidine" nke ntụziaka na-egosi n'okpuru, na-emepụta dị iche iche doses - 40 na 20 mg.

Atụmatụ nke ọgwụ

Tupu anyị azaa ajụjụ nke ihe na-eme ka "famotidine" ga-agwa anyị otú anyị na ọgwụ na-arụ ọrụ. Dị ka ntụziaka, isiokwu gị n'ụlọnga bụ a blocker nke H2-histamine anabata. Ọ na-egosi mgbochi ọnyá Njirimara.

Isi umi nke ọgwụ na-eme ka suppression nke basal acid ngwaahịa (hydrochloric acid) na afo. Ọzọkwa, famotidine ebelata mmetuta nke histamine, acetylcholine na gastrin na gastric ihe ọṅụṅụ na-enwekwu pH, pepsin ọrụ na-ebelata na mmepụta nke HCL.

N'ihi nke a na ụba larịị nke glycoprotein guzobere pụtara abawanye gastric imi na mmetuta nke prostaglandin njikọ. Site na secretion nke hydrogen enweta na zọcha ọnya-agwọ Njirimara nke ọgwụ.

E lee ya anya ọgwụ na-enyere kwụsị ọbara ọgbụgba site na afo, na-agwọ mmebi na ya mucous na n'ichihịa nchegbu onya.

Njirimara nke ọgwụ

Nkwadebe "Famotidine" (analogs price ọgwụ ọjọọ ndị e depụtara n'okpuru ebe a) nwere obere mmetụta okwu usoro (oxidase) enzyme cytochrome P450 na imeju.

Mmetụta ya nke ọma a ọgwụ amalite mgbe 65 nkeji, ọ na-ewe banyere a ụbọchị.

The kinetics nke ọgwụ

The agwọ ọrịa "Famotidine", onye agụ na-ọkọnọ n'okpuru, mgbe onu ochichi na-etinye obi gị dum na eriri afọ. Ya ịta (kacha) ọbara-enweta n'ime awa atọ.

Communication ọgwụ na plasma-edozi bụ 15-20%. Ọ na-anyụpụ na mmiri ara nne na penetrates site na placental mgbochi.

Odika 30-35% nke nọ n'ọrụ ọgwụ umi n'okpuru echiche na-metabolized na imeju. Nke a Nleta S-oxide.

Mkpochapu ngwá ọrụ na-ewe ebe tumadi site na akụrụ ya. Odika 27-40% nke ọgwụ na-anyụpụ na mmamịrị na-agbanweghi agbanwe ụdị. ọkara ndụ "nke famotidine" oge bụ 3-4 awa. Ndị na-CC erughị 30 ml kwa nkeji a index na-ụba na-11-12 awa.

Site na ihe na-enyere "famotidine"?

Mgbe ụfọdụ, akuko ọgwụ kenyere onye dọkịta? Dị ka ntụziaka, na-enweta na-egosi nke a ọgwụ na-na-esonụ na-ekwu:

• mastocytosis usoro;
• nlọghachi azụ mgbochi, digestive tract ọnyá afọ ọrịa;
• reflux esophagitis;
• erosive gastro;
• mgbochi nke nlọghachi azụ, nke na-metụtara ruo ogologo oge iji NSAIDs;
• Zollinger-Ellison syndrome;
• ọtọ dyspepsia, nke a na-ejikọta ya na ụba na-arụ ọrụ (secretory) nke afo;
• eriri afọ ọnyá, nchegbu na symptomatic;
• Prevention of ọchịchọ nke gastric ihe ọṅụṅụ na ọrịa emume ịwa n'okpuru general ná Nkụnwụ (i.e. Mendelson si syndrome);
• multiple endocrine adenomatosis;
• mgbochi nke nlọghachite nke na-agba ọbara, gụnyere post-ịkpa oge;
• Prevention of ọchịchọ pneumonitis;
• neuralgia na ihe mgbu na retrosternal ma ọ bụ epigastric mgbu na-erukwa n'abalị ma ọ bụ ndị a na-ingestion nke iri ihe ụfọdụ.

Bans na-eji ọgwụ ọjọọ

Ugbu a ị maara, ihe na-enyere "famotidine". Ma tupu i mee nke a na nkà mmụta ọgwụ, ị kwesịrị ị mara nke ọma na ntuziaka. Nke a na ọgwụ na-contraindicated na-enweta na:

• lactation;
• na ụmụaka na-erubeghị afọ atọ (arọ ahụ erughị 20 n'arọ);
• gestation;
• hypersensitivity ka famotidine, ọzọ blockers na H2-histamine anabata.

Na pụrụ iche ịkpachara anya si ọgwụ kenyere hepatic ma ọ bụ gbasara akụrụ insufficiency, immunosuppression, imeju imeju na portosystemic encephalopathy na ụmụ.

Olee otú ga-ewere "famotidine"?

Nke a na ọgwụ a na-kenyere n'ime. Ekwela ata mbadamba, na asa ala na zuru ezu ego nke mmiri mmiri.

Meworo okenye weere ọgwụ kwesịrị naanị inye a dọkịta (dabere na ndị na-egosi).

N'oge ọnyá afọ nke digestive tract, karịsịa na nnukwu-adọ nakwa dị ka ọnyá na symptomatic gastroduodenite erosive ifịk agwọ ọrịa nwere ike ikwu na-ewere 20 mg ugboro abụọ n'ụbọchị, ma ọ bụ otu ugboro na ego nke 40 mg (chi). Ọ bụrụ na chọrọ, kwa ụbọchị onunu ogwu nke ọgwụ nwere ike gbanwere na ụba na 80-160 mg.

Na oge nke ọgwụgwọ na a gị n'ụlọnga bụ 6-8 izu.

N'ihi mgbochi nke ọnyá afọ Nlọghachi ọgwụ "Famotidine" contraindications nke e depụtara, 20 mg ndinọ otu ugboro n'ụbọchị, na alakpu ụra.

Mgbe dyspepsia, nke a na-ejikọta na ụba secretion nke afo, ọgwụ na-atụ aro na-n'otu usoro onunu ogwu.

Ọ bụrụ na e refpyuks oesophagitis ọgwụ eji ugboro abụọ n'ụbọchị nke 20-40 mg maka 6-12 izu.

Iji gbochie ọchịchọ nke gastric ihe ọṅụṅụ n'okpuru general ná Nkụnwụ agwọ ọrịa na-ndinọ ke ichekwa 40 mg na mgbede ma ọ bụ ozugbo tupu ịwa ahụ.

Mgbe Zollinger-Ellison syndrome na onunu ogwu na oge nke ya ngwa na-setịpụrụ n'otu n'otu. A, mbụ dose of ọgwụ bụ 20 mg. Were a usọbọ kwesịrị ọ bụla awa isii. Ọ bụrụ na chọrọ, ego nke agwọ ọrịa nwere ike ụba na 160 mg n'otu n'ikuku ugboro.

Na ọnụnọ nke gbasara akụrụ odida (e.g., CC erughị 30 ml kwa nkeji) kwa ụbọchị dosing n'aka ga-ebelata ka 20 mg.

Dosing na ụmụ

Site na ihe na-enyere "famotidine" ụmụ? Nke a pụtara na na kenyere maka otu ihe mere dị ka okenye. Gi ọnyá afọ na ihe exacerbation adọ, na reflux esophagitis na-atụ aro na-ọgwụ dị ka ndị na-esonụ atụmatụ: 2 mg kwa 1 n'arọ nke ahu arọ kwa ụbọchị. Nke a buru ibu nke ọgwụ na-kewara abụọ nzọụkwụ.

mmetụta

Weere n'aka ike ime ka ndị dị otú ahụ mmetụta ndị dị ka:

• akọrọ ọnụ, arrhythmia, ọgbụgbọ, otutu vulgaris, vomiting;
• alopecia, abdominal mgbu, akọrọ anụ ahụ, bloating, ebelata ọbara mgbali, afọ ntachi;
• akpụkpọ ọkụ ọkụ, afọ ọsịsa, AV-ngọngọ, agụụ na-anaghị ekwe, angioedema;
• ịba ọcha n'anya, itching, elu imeju enzymes, anaphylactic ujo;
• nnukwu pancreatitis, hypersensitivity mgbaàmà, isi ọwụwa;
• bronchospasm, dizziness, hyperthermia, ehighi ura, ulo paresis;
• bradycardia, nchegbu, mgbagwoju anya, tinnitus, vasculitis;
• leukopenia, ike ọgwụgwụ, mụbara ọbara urea etoju, ịmụ anya arọ nrọ, agranulocytosis, iro ụra;
• thrombocytopenia, ịda mbà n'obi, hypoplasia, ịma jijiji, pancytopenia, psychosis;
• ụmị ọkpụkpụ aplasia, bịara ikiri ọhụụ, hyperprolactinemia;
• fever, ọnwụ nke libido, nkwonkwo mgbu, gynecomastia, enweghi ike, amenorrhea, muscle aches.

Na-eri na analogues

The na-eri nke ngwaahịa a dị ka "famotidine" bụ banyere 30-55 rubles. Ọ bụrụ na ọ dị mkpa, ọ ga-anọchi analogues dị ka "Gastromaks", "Kvamatel", "Gastrotid", "ulfamid", "Famozol", "Famodingeksal", "Famosan".

ọgwụ Nyocha

Drug "famotidine" - a nnọọ ewu ewu mgbochi ọnyá gị n'ụlọnga. Ọrịa na-ekwu na ọ dị irè na-egosipụta onwe ya na ọrịa ndị a na-eriri afọ tract. Ọtụtụ mgbe ọ na-kenyere mgbu na onya.

Ọzọ uru nke a ọgwụ bụ ya ikwu cheapness.

Ma ihe ndị na-ezighị ezi reviews, mgbe ahụ, ha dị nnọọ nkịtị mkpesa banyere mmetụta nke ọgwụ.